Dr. Reddy's Laboratories
RDY
#1699
Rank
S$15.38 B
Marketcap
S$18.39
Share price
0.35%
Change (1 day)
-4.47%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.85 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total debt is S$0.85 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dr. Reddy's Laboratories - Total debt on balance sheet (from 2001 to 2025)

Total debt by year

Year Total debt Change
2025-03-31S$0.73 B127.1%
2024-03-31S$0.32 B48.41%
2023-03-31S$0.21 B-63.88%
2022-03-31S$0.60 B8.43%
2021-03-31S$0.55 B33.49%
2020-03-31S$0.41 B-44.28%
2019-03-31S$0.74 B-26.71%
2018-03-31S$1.02 B-3.56%
2017-03-31S$1.05 B55.27%
2016-03-31S$0.68 B-28.24%
2015-03-31S$0.95 B1.28%
2014-03-31S$0.93 B11.66%
2013-03-31S$0.84 B5.58%
2012-03-31S$0.79 B19.13%
2011-03-31S$0.66 B44.67%
2010-03-31S$0.46 B-21.99%
2009-03-31S$0.59 B-11.1%
2008-03-31S$0.66 B-23.61%
2007-03-31S$0.87 B-22.7%
2006-03-31S$1.12 B946.2%
2005-03-31S$0.10 B453.8%
2004-03-31S$19.46 M58.85%
2003-03-31S$12.25 M112.33%
2002-03-31S$5.77 M-96.23%
2001-03-31S$0.15 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
S$78.85 B 9,134.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$22.12 B 2,491.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$30.92 B 3,521.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$41.49 B 4,759.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$33.08 B 3,774.71%๐Ÿ‡ซ๐Ÿ‡ท France